Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3393648
Max Phase: Preclinical
Molecular Formula: C22H11Cl5N2O4
Molecular Weight: 544.61
Molecule Type: Small molecule
Associated Items:
ID: ALA3393648
Max Phase: Preclinical
Molecular Formula: C22H11Cl5N2O4
Molecular Weight: 544.61
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(c1ccccc1O)c1[nH]c(Cl)c(Cl)c1-n1c(C(=O)c2ccc(Cl)cc2O)cc(Cl)c1Cl
Standard InChI: InChI=1S/C22H11Cl5N2O4/c23-9-5-6-11(15(31)7-9)19(32)13-8-12(24)22(27)29(13)18-16(25)21(26)28-17(18)20(33)10-3-1-2-4-14(10)30/h1-8,28,30-31H
Standard InChI Key: SUAOKGAOBSNFQV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 544.61 | Molecular Weight (Monoisotopic): 541.9161 | AlogP: 6.95 | #Rotatable Bonds: 5 |
Polar Surface Area: 95.32 | Molecular Species: ACID | HBA: 5 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 6.26 | CX Basic pKa: | CX LogP: 7.92 | CX LogD: 6.37 |
Aromatic Rings: 4 | Heavy Atoms: 33 | QED Weighted: 0.24 | Np Likeness Score: -0.26 |
1. Li R, Cheng C, Balasis ME, Liu Y, Garner TP, Daniel KG, Li J, Qin Y, Gavathiotis E, Sebti SM.. (2015) Design, synthesis and evaluation of marinopyrrole derivatives as selective inhibitors of Mcl-1 binding to pro-apoptotic Bim and dual Mcl-1/Bcl-xL inhibitors., 90 [PMID:25437618] [10.1016/j.ejmech.2014.11.035] |
2. Yang Z, Liu Y, Ahn J, Qiao Z, Endres JL, Gautam N, Huang Y, Li J, Zheng J, Alnouti Y, Bayles KW, Li R.. (2016) Novel fluorinated pyrrolomycins as potent anti-staphylococcal biofilm agents: Design, synthesis, pharmacokinetics and antibacterial activities., 124 [PMID:27565555] [10.1016/j.ejmech.2016.08.017] |
Source(1):